Prostate cancer is one of the most common cancers in men, and early detection can significantly improve treatment outcomes. It originates in the prostate gland, which is responsible for producing seminal fluid. While prostate cancer typically grows slowly, it can become aggressive in some cases and spread to other parts of the body.
The exact causes of prostate cancer are not fully understood, but several risk factors can contribute to its development:
The risk of prostate cancer increases significantly after age 50.
A family history of prostate cancer can increase the risk.
Certain inherited gene mutations (like BRCA1 and BRCA2) may contribute.
Obesity, smoking, and lack of physical activity may contribute to a higher likelihood of developing prostate cancer.
A diet high in red meat and dairy products, with low fruit and vegetable intake, can increase the risk.
In its early stages, prostate cancer may not present any noticeable symptoms. However, as the disease progresses, symptoms may include:
Prostate cancer is diagnosed through several methods, often starting with a physical examination and screening tests:
Treatment for prostate cancer depends on the stage and grade of the disease, as well as the patient's overall health. The most common treatments include:
Radical Prostatectomy: Removal of the prostate gland, often used for early-stage cancer.
Robotic-Assisted Surgery (Robotic Prostatectomy): Robotic surgery is a minimally invasive technique that uses robotic arms controlled by a surgeon to perform precise procedures. This method offers improved accuracy, reduced blood loss, less postoperative pain, and quicker recovery compared to traditional surgery. Robotic prostatectomy has become a preferred choice for many patients due to its advanced capabilities and better functional outcomes, including urinary control and sexual function.
Hormone therapy is used to lower testosterone levels, as the hormone stimulates prostate cancer growth.
Chemotherapy may be used in cases where the cancer has spread beyond the prostate and is no longer responding to hormone therapy.
Radiation therapy plays a crucial role in treating prostate cancer, particularly for patients who are not candidates for surgery or those with localized tumors. The latest advancements in radiation therapy allow for more precise treatments, minimizing side effects and improving patient outcomes.
Proton therapy is an advanced form of radiation that uses protons instead of traditional X-rays to target cancer cells. Its precision ensures that the surrounding healthy tissues, such as the bladder and rectum, are spared from excessive radiation exposure. Proton therapy allows for higher doses of radiation to be delivered directly to the tumor, reducing side effects and improving long-term outcomes for prostate cancer patients.
CyberKnife is a non-invasive robotic system that delivers targeted radiation with pinpoint accuracy. It tracks the prostate’s movement in real-time, ensuring that the tumor receives the full radiation dose while avoiding nearby healthy tissues. CyberKnife treatment for prostate cancer is typically completed in fewer sessions compared to traditional radiation therapy, offering a quicker and more convenient option for patients. The treatment is painless and does not require surgery or anesthesia.
No Incision: These non-invasive treatments eliminate the need for surgical procedures.
No Blood Loss: With no surgery involved, there is no risk of blood loss.
No Pain: Both treatments are painless, offering comfort to patients during therapy.
No Anesthesia: Since there’s no surgery, anesthesia is not required.
No Admission: Proton Therapy and CyberKnife are typically performed on an outpatient basis, allowing patients to return home the same day.
Healthcare International is a medical value travel undertaking that connects patients with world-class healthcare services across India and other medical destinations. It is a top-tier hospital network and over hundreds of expert clinicians to accord personalized care, advanced treatment, and global access to ensure the best possible medical outcomes for each of its patients.
Copyright © 2024, Healthcare International
